Third Harmonic Bio Statistics
Total Valuation
THRD has a market cap or net worth of $461.29 million. The enterprise value is $195.72 million.
| Market Cap | 461.29M |
| Enterprise Value | 195.72M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
THRD has 40.71 million shares outstanding. The number of shares has increased by 176.21% in one year.
| Shares Outstanding | 40.71M |
| Shares Change (YoY) | +176.21% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 10.01% |
| Owned by Institutions (%) | 93.35% |
| Float | 8.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 50.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 50.29 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -11.20% and return on invested capital (ROIC) is -16.10%.
| Return on Equity (ROE) | -11.20% |
| Return on Assets (ROA) | -10.80% |
| Return on Capital (ROIC) | -16.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.03M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +169.76% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +169.76% |
| 50-Day Moving Average | 10.12 |
| 200-Day Moving Average | 8.24 |
| Relative Strength Index (RSI) | 57.75 |
| Average Volume (30 Days) | 148,096 |
Short Selling Information
The latest short interest is 682,559, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 682,559 |
| Short Previous Month | 659,238 |
| Short % of Shares Out | 1.68% |
| Short % of Float | 7.62% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.95M |
| Pretax Income | -30.82M |
| Net Income | -30.82M |
| EBITDA | -30.23M |
| EBIT | -30.82M |
| Earnings Per Share (EPS) | -$0.78 |
Balance Sheet
The company has $269.52 million in cash and $3.95 million in debt, giving a net cash position of $265.57 million or $6.52 per share.
| Cash & Cash Equivalents | 269.52M |
| Total Debt | 3.95M |
| Net Cash | 265.57M |
| Net Cash Per Share | $6.52 |
| Equity / Book Value | 269.09M |
| Book Value Per Share | 6.61 |
| Working Capital | 267.03M |
Cash Flow
In the last 12 months, operating cash flow was -$20.43 million and capital expenditures -$169,000, giving a free cash flow of -$20.59 million.
| Operating Cash Flow | -20.43M |
| Capital Expenditures | -169,000 |
| Free Cash Flow | -20.59M |
| FCF Per Share | -$0.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THRD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -176.21% |
| Shareholder Yield | -176.21% |
| Earnings Yield | -6.68% |
| FCF Yield | -4.46% |
Analyst Forecast
The average price target for THRD is $7.00, which is -38.22% lower than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | -38.22% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |